Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
$2.11
+0.2%
$2.62
$1.98
$22.25
$16.84M-0.4667,353 shs31,603 shs
electroCore, Inc. stock logo
ECOR
electroCore
$5.11
-2.9%
$6.13
$4.16
$19.49
$40.27M0.36124,746 shs99,873 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.25
-3.8%
$4.28
$3.03
$9.33
$55.73M1.41204,589 shs101,590 shs
TELA Bio, Inc. stock logo
TELA
TELA Bio
$1.65
-5.2%
$1.85
$0.86
$3.26
$70.52M0.8496,414 shs136,383 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
+0.96%-4.75%-26.14%-22.75%-87.54%
electroCore, Inc. stock logo
ECOR
electroCore
-2.85%-7.93%-29.52%-4.66%-16.23%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-3.85%+2.20%-40.91%-35.39%-48.33%
TELA Bio, Inc. stock logo
TELA
TELA Bio
-5.17%-6.25%-10.81%-15.38%-40.22%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
2.7118 of 5 stars
3.45.00.00.02.20.00.6
electroCore, Inc. stock logo
ECOR
electroCore
2.5278 of 5 stars
3.51.00.00.02.72.50.6
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.969 of 5 stars
3.51.00.00.03.01.70.0
TELA Bio, Inc. stock logo
TELA
TELA Bio
2.3124 of 5 stars
3.32.00.00.02.61.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
2.80
Moderate Buy$22.83984.72% Upside
electroCore, Inc. stock logo
ECOR
electroCore
3.00
Buy$25.50399.02% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$8.00146.15% Upside
TELA Bio, Inc. stock logo
TELA
TELA Bio
2.50
Moderate Buy$4.50172.73% Upside

Current Analyst Ratings Breakdown

Latest ALUR, SRTS, TELA, and ECOR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
8/12/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $8.00
8/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $6.00
(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
$32.11M0.51N/AN/A($8.24) per share-0.26
electroCore, Inc. stock logo
ECOR
electroCore
$25.18M1.54N/AN/A$0.15 per share34.07
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.28$0.41 per share7.85$3.17 per share1.03
TELA Bio, Inc. stock logo
TELA
TELA Bio
$69.30M0.94N/AN/A$0.23 per share7.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
-$7.20M-$12.53N/AN/AN/A-158.30%N/A-59.91%11/12/2025 (Estimated)
electroCore, Inc. stock logo
ECOR
electroCore
-$11.89M-$1.62N/AN/AN/A-47.84%-221.93%-69.17%11/12/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M-$0.06N/A14.13N/A-2.26%-1.58%-1.41%11/13/2025 (Estimated)
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$37.84M-$1.12N/AN/AN/A-54.12%-329.48%-57.34%11/6/2025 (Estimated)

Latest ALUR, SRTS, TELA, and ECOR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/19/2025Q2 2025
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
-$0.65-$0.57+$0.08-$1.28$6.20 million$3.38 million
8/11/2025Q2 2025
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$0.18-$0.22-$0.04-$0.22$20.67 million$20.20 million
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
8/6/2025Q2 2025
electroCore, Inc. stock logo
ECOR
electroCore
-$0.32-$0.35-$0.03-$0.44$7.24 million$7.38 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
N/AN/AN/AN/AN/A
electroCore, Inc. stock logo
ECOR
electroCore
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
N/A
2.02
1.70
electroCore, Inc. stock logo
ECOR
electroCore
N/A
1.10
0.95
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.14
5.79
TELA Bio, Inc. stock logo
TELA
TELA Bio
4.14
3.19
2.59

Institutional Ownership

CompanyInstitutional Ownership
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
21.39%
electroCore, Inc. stock logo
ECOR
electroCore
26.74%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
TELA Bio, Inc. stock logo
TELA
TELA Bio
94.35%

Insider Ownership

CompanyInsider Ownership
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
9.60%
electroCore, Inc. stock logo
ECOR
electroCore
13.80%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
TELA Bio, Inc. stock logo
TELA
TELA Bio
4.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
5017.76 million7.02 millionOptionable
electroCore, Inc. stock logo
ECOR
electroCore
507.58 million6.54 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable
TELA Bio, Inc. stock logo
TELA
TELA Bio
12039.62 million37.75 millionOptionable

Recent News About These Companies

TELA Bio (NASDAQ:TELA) Issues Earnings Results
TELA Bio, Inc. (TELA) Q2 2025 Earnings Call Transcript
TELA Bio Reports Second Quarter 2025 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Allurion Technologies stock logo

Allurion Technologies NYSE:ALUR

$2.10 +0.01 (+0.24%)
Closing price 09/3/2025 03:59 PM Eastern
Extended Trading
$2.12 +0.02 (+0.95%)
As of 09/3/2025 06:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

electroCore stock logo

electroCore NASDAQ:ECOR

$5.11 -0.15 (-2.85%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$5.27 +0.16 (+3.11%)
As of 09/3/2025 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.25 -0.13 (-3.85%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$3.29 +0.04 (+1.20%)
As of 09/3/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

TELA Bio stock logo

TELA Bio NASDAQ:TELA

$1.65 -0.09 (-5.17%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$1.65 0.00 (0.00%)
As of 09/3/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.